DiNuzzo Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Sell
214
-1
-0.5% -$57 ﹤0.01% 258
2026
Q1
$13K Buy
215
+16
+8% +$933 ﹤0.01% 241
2025
Q4
$10.7K Buy
199
+21
+12% +$1.01K ﹤0.01% 262
2025
Q3
$8.4K Sell
178
-6
-3% -$280 ﹤0.01% 288
2025
Q2
$8.52K Sell
184
-18
-9% -$884 ﹤0.01% 288
2025
Q1
$12.3K Buy
202
+14
+7% +$816 ﹤0.01% 222
2024
Q4
$10.6K Sell
188
-6
-3% -$335 ﹤0.01% 235
2024
Q3
$10K Buy
194
+5
+3% +$235 ﹤0.01% 252
2024
Q2
$7.85K Buy
189
+21
+13% +$940 ﹤0.01% 220
2024
Q1
$9.11K Hold
168
﹤0.01% 186
2023
Q4
$8.62K Buy
+168
New +$8.82K ﹤0.01% 186

Other funds holding BMY

DiNuzzo Private Wealth's BMY Position: Q2 2026 in Review

DiNuzzo Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 0.47% in Q2 2026, selling an estimated $57 and leaving 214 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

DiNuzzo Private Wealth first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $13K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • DiNuzzo Private Wealth held 214 shares of Bristol-Myers Squibb worth $12.3K as of Q2 2026.
  • DiNuzzo Private Wealth sold 1 Bristol-Myers Squibb share in Q2 2026, an estimated $57.
  • Bristol-Myers Squibb made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #258 holding.
  • DiNuzzo Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • DiNuzzo Private Wealth's Bristol-Myers Squibb position peaked at $13K in Q1 2026.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.